CERO THERAPEUTICS HOLDINGS, INC. Prepaid Expense and Other Assets, Current
CERO THERAPEUTICS HOLDINGS, INC. (CERO) had Prepaid Expense and Other Assets, Current of $610.44 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › and Other Assets
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-14
- 2026-06-30: Prepaid Expense and Other Assets, Current $610.44K.
- 2026-03-31: Prepaid Expense and Other Assets, Current $716.91K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $1.07M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $531.83K.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $610.44K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $716.91K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $1.07M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $531.83K 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $443.89K 10-Q · filed 2025-08-22 | |
| 2025-03-31 | $564.46K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $274.75K 10-K · filed 2026-04-15 | |
| 2024-09-30 | $334.28K 10-Q/A · filed 2024-11-20 | |
| 2024-06-30 | $511.46K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $746.04K 10-Q · filed 2024-05-17 | |
| 2023-12-31 | $368.78K 10-K · filed 2025-04-15 | $27.43K 10-K · filed 2024-04-02 |
| 2023-09-30 | $21.82K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $107.98K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $220.29K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $225.19K 10-K · filed 2024-04-02 | |
| 2022-09-30 | $277.38K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $292.25K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $307.13K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $262.50K 10-K · filed 2023-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |